Skip to content
Crystal Gamble Zone

{‘She possesses no qualifications’: the US medical field braces for Høeg's appointment at the FDA.

While America undertakes historic changes to its vaccination recommendations, one figure appears unexpectedly: Høeg, a US-based sports medicine doctor and epidemiologist who first made her name by casting doubt on coronavirus vaccinations during the pandemic and has zeroed in on alleged deaths following COVID-19 vaccination in her short position at the FDA.

Proposed Shifts to Childhood Immunization Schedule

Agency leaders were set to reveal major changes to the childhood vaccine schedule earlier this month, bringing the US with the Danish vaccine program, sources say – a major change that would place the US at odds with much of the global community with no evidence for improved outcomes. This reveal has been delayed until the coming year.

Rather than the director of the vaccine center, Høeg is set to present at the meeting. She was recently named acting director of the FDA’s CDER, the fifth appointee to run the office this year.

Consolidating Power at the FDA

Høeg's temporary position could signify a strengthened alliance between the pharmaceutical and biologics branches as Høeg and Prasad solidify control at the FDA – and it points to a renewed priority upon reevaluating long-standing immunizations at the FDA.

Dr. Høeg has frequently advocated for discontinuing some pediatric immunization guidelines in the US so as to align more similar to Denmark, a nation with comprehensive healthcare and a number of inhabitants approximately the population of the state of Wisconsin.

So far public appearances, she has persisted in emphasizing on vaccines – typically the purview of Dr. Prasad, chief of the FDA’s Center for Biologics Evaluation and Research (CBER) – rather than medication approval.

Questions Over Qualifications

Høeg has no obvious track record in pharmaceutical research, oversight or leadership, which has been standard for former directors of the CBER. She has served at the FDA as a key advisor to the FDA chief and the vaccine center since spring.

“She appears not to have the necessary background” for leading the CDER, stated a neurologist and psychiatrist. “She’s never run a clinical trial. She lacks experience in running a large organization. She is not an expert in industry regulation.”

Previous heads of the center would “grasp regulatory frameworks and the science of medication creation”, said a former acting FDA commissioner. “Clearly, she doesn’t have the type of experience that previous people who headed the center have had.”

CDER has an vast workload at the agency, she emphasized.

“Everybody just focuses on the new drug program, but the generic program authorizes thousands of generic medications. There’s a biosimilars program, non-prescription drug unit and so forth, and all of those must be managed,” Woodcock said. “The area you overlook, that’s the thing that I always told people is going to bite you.”

Additionally, a significant leadership aspect to the job, which oversees over 5,000 staff members. “It is a huge administrative position, if you perform it correctly,” the former official said.

Official Statement and Contentious Policies

In response to concerns about Høeg’s fitness for the role and whether this appointment indicates increased cooperation among FDA leaders on immunizations, a press secretary said that the “questions are based on flawed premises”.

“This background is consistent with the functions of her position,” the spokesperson stated, pointing to the months Dr. Høeg spent guiding the agency head on “drug safety and approval science, including predictive safety algorithms and vaccine surveillance”.

As acting director, Dr. Høeg assumes responsibility for the agency head's controversial expedited review system, a disputed rapid therapy clearance system that allegedly worried her former heads. “How are these drugs being selected for this fast-track system? Who is making the choices?” Dr. Howard said. “There’s a lot of secrecy happening at the regulatory body right now.”

Overall, he stated, “the Food and Drug Administration looks to be trending towards laxer regulations of all drugs, except for vaccines.”

Public Past Work on Vaccines

With immunizations, Dr. Høeg has a more established, if troubling, track record, critics said. She authored a study using unverified crowd-sourced reports to determine the rate of heart inflammation following COVID-19 vaccination. She advised the state of Florida chief medical officer Dr. Joseph Ladapo, who was said to have altered data to imply Covid vaccines are more dangerous than they are.

Among her “desired changes” for the incoming federal leadership featured changing rules for new vaccines and halting “unnecessary” immunizations, she said after the election on a podcast. At the agency, Høeg has according to sources proposed preventing adolescent males from receiving COVID-19 vaccines.

“She’s an all-around true believer who commences with her conclusions and tailors the evidence to fit the data in a extremely deceptive, untruthful way,” Dr. Howard stated.

Consolidating Power and a “Revenge Tour”

Høeg aligned with other contrarians, {like|

About the author

Todd Cox

A seasoned casino strategist with over a decade of experience in gaming analysis and player psychology.

Crystal Gamble Zone

Type to search articles.